If you’ve been on the cortisone cycle for months — or years — there’s something most patients are never told before they roll up their sleeve.
What the research actually shows
A 2020 study published in the journal Radiology examined patients receiving repeated intra-articular corticosteroid injections and found something unexpected. The injections weren’t simply failing to improve outcomes — in many cases, they were associated with accelerated joint degeneration. Cartilage was breaking down faster than it would have without the shots.
This wasn’t fringe research. It was published in one of the most respected radiology journals in the world. And it changed the conversation around steroid injections — at least for clinicians paying attention.
Why this happens at the cellular level
Cortisone is a glucocorticoid. With repeated exposure, the cartilage cells responsible for maintaining and repairing joint tissue — the chondrocytes — begin to die off. Those are the exact cells your joint depends on to stay healthy.
In the short term, the inflammation calms down and the joint feels better. Underneath that relief, however, the structural integrity of the joint can continue to deteriorate. The next flare comes sooner. The pain comes back deeper. And the cycle compounds.
The cumulative dose problem nobody is tracking
Here’s a layer of this issue most patients never hear about: many people aren’t getting injections from a single physician. They’re getting them from an orthopedist, a primary care doctor, a rheumatologist, a podiatrist — sometimes all in the same year.
Nobody is keeping a running total. We’ve seen patients who have received fifteen to twenty corticosteroid injections in a single twelve-month period. The original safety studies that established cortisone as a routine option were based on three or four — not fifteen.
Where cortisone still has a legitimate role
We don’t think corticosteroid injections are inherently bad. Used appropriately — for an acutely inflamed joint, in a true flare, in a true emergency — they can serve a real clinical purpose. The issue is the long-term, repeat use as a primary management strategy. That’s where the risk profile changes.
What we educate patients to ask
If you’ve been on the cortisone cycle and the joint keeps getting worse over time, that pattern is worth examining. The questions worth raising with any provider include:
How many corticosteroid injections have I received in the last twelve months — across all providers? What does the imaging show now compared to a year ago? Are we managing inflammation, or are we addressing the underlying structural picture?
The goal isn’t to villainize any one therapy. It’s to make sure the conversation is honest and the strategy is current.
Why this matters
Pain relief that comes at the cost of accelerated tissue breakdown isn’t really pain relief — it’s borrowing from a future you may regret later. The longer the cycle continues, the fewer options remain when the joint can no longer compensate.
Regenerative biologics aren’t the answer to every joint complaint, and we don’t pretend otherwise. But for patients caught in a long cortisone loop, there’s a different conversation worth having — one that focuses on supporting the body’s natural repair processes rather than suppressing inflammation indefinitely.
REQUIRED DISCLAIMER
Educational content only. The information presented in this article is for general informational and educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. RegenHaus uses 361 HCT/P regenerative biologics, which are not FDA-approved to treat or cure any condition. Individual results vary. Please consult a licensed medical provider before considering any therapy or making changes to your health regimen.
